Atrial natriuretic peptide and c-type natriuretic peptide do not acutely inhibit the release of adrenocorticotropin from equine pituitary cells in vitro

Neuroendocrinology

Volumn 65, Issue 1, 1997, Pages 64-69

  Mulligan, Rachel S ^a   Livesey, John H ^a   Evans, Margaret J ^a   Ellis, M Jane ^a   Donald, Richard A ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Atrial natriuretic peptide; Horse

Indexed keywords

ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; NATRIURETIC PEPTIDE TYPE C;

ANIMAL CELL; ARTICLE; CORTICOTROPIN RELEASE; HORSE; HYPOPHYSIS CELL; NONHUMAN; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ARGININE VASOPRESSIN; ATRIAL NATRIURETIC FACTOR; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HORSES; HYDROCORTISONE; KINETICS; MALE; NATRIURETIC PEPTIDE, C-TYPE; PITUITARY GLAND, ANTERIOR; PROTEINS;

EID: 0031026081     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000127165     Document Type: Article

References (32)

1. Donald RA, Wittert GA: Stress and corticotropin regulation, CurrOpin Endocrinol Diabetes 1994;1:93-99.
2. Engler D, Liu J-P, Clarke U, Funder JW: Corti-cotropin-release inhibitory factor, Trends Endocrinol Mctab 1994;5:272-283.
3. Grossman A, Tsagarakis S: The hunt for the CIA: Factors which demonstrate corticotro-phin-inhibitory activity, J Endocrinol 1989: 123:169-172.
4. Yandle TG: Biochemistry of natriuretic peptides, J Intern Med 1994:235:561-576.
5. Lim AT, Dow RC, Yang Z, Fink G: ANP(5-28) is the major molecular species in hypophysial portal blood of the rat, Peptides 1994:15: 1557-1559.
6. Antoni FA, Dayanithi G: Secretion of ACTH by perifused isolated rat anterior pituitary cells: Pulses of secrctagogue enhance the secretory response and modify the effect of alriopeptin, J Endocrinol 1990;125:365-373.
7. Dayanithi G, Antoni FA: Atriopcptins are potent inhibitors of ACTH secretion by rat anterior pituitary cells in vivo: Involvement of the atrial natriuretic factor receptor domain of membrane-bound guanyl cvclasc, J Endocrinol 1990;125:39-44.
8. Kellner M, Wiedmann K, Holsboer F: Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTI1 and cortisol in man, Life Sei 1992;50:1835-1842.
9. Kovacs K, Antoni FA: Atriopeptin inhibits stimulated secretion of adrcnocorticotropin in rats: Evidence for a pituitary site of action, Endocrinology 1990:127:3003-3008.
10. Wittert GA, Espiner EA, Richards AM, Donald RA, Livesey JH, Yandle TG: Atrial natriuretic factor reduces vasopressin and angiotensin II but not the ACTH response to acute hypoglycaemia in normal man, Clin Endocrinol (Oxt) 1993;38:183-189.
11. Ur E, Faria M, Tsagarakis S, Anderson JV, Besser GM, Grossman A: Atrial natriuretic peptide in physiological doses docs not inhibit the ACTH or cortisol response to corticotro-phin-releasing hormone-41 in normal human subjects, J Endocrinol 1991;131:163-167.
12. Hashimoto K, Hattori T, Sucmaru S, Sugawara M, Takao T, Kagcvama J, Ota Z: Atrial natriuretic peptide does not affect corticotropin-releasing factor-, arginine vasopressin- and an-giotensin-Il-induced adrenocorticotropic hormone release in vivo or in vitro, Regul Pcpt 1987;17:53-60.
13. Cunco RC, Espiner EA, Nichols MG, Yandle TG, Livesey JH: Effect of physiological levels of atrial natriuretic peptide on hormone secretion: Inhibition of angiotensin-induced aldosterone secretion and renin release in normal man, J Clin Endocrinol Metab 1987;65:765-772.
14. Engler D, Pham T, Liu J-P, Fullerton MJ, Clarke IJ, Funder JW: Studies of the regulation of the hypothalamic-pituitary-adrenal axis in sheep with hvpolhalamic-pituitary disconnection, II, Evidence for in vivo ultradian hypersecretion of proopiomelanocortin peptides by the isolated anterior and intermediate pituitary, Endocrinology 1990; 127:1956-1966.
15. Cameron VA, Espiner EA, Nichols MG, Skidmore DS: Hormone and hemodynamic responses to atrial natriuretic peptide in conscious sheep and effect of haemorrhage, Endocrinology 1988:122:407-414.
16. Vermes I, Beishuizcn A, Hantpsink RM, Haan-en C: Dissociation of plasma adrenocorticotro-pin and cortisol levels in critically ill patients: Possible role of endothelin and atrial natriuretic hormone, J Clin Endocrinol Metab 1995:80: 1238-1242.
17. Fink G, Dow RC, Casley D, Johnston CL Bennie J, Carroll S, Dick H: Atrial natriuretic peptide is involved in the ACTH response to stress and glucocorticoid negative feedback in the rat, J Endocrinol 1992;135:37-42.
18. Fink G, Dow RC, Casley D, Johnston CI, Lim AT, Copolov DL, Bennie J, Carroll S, Dick H: Atrial natriuretic peptide is a physiological inhibitor of ACTH release: Evidence from immunoneutralization in vivo, J Endocrinol 1991:131:R9-R12.
19. Evans MJ, Marshall AG, Kitson NE, Summers K, Donald RA: Factors affecting ACTH release from perifused equine anterior pituitary cells, J Endocrinol 1993:137:391-401.
20. Evans MJ, Kitson NE, Livesey JH, Donald RA: The effect of cortisol on the secretion of ACTH by anterior pituitary' cells of the horse in culture, J Endocrinol 1993;137:403-412.
21. Alexander SL, Irvine CHG, Donald RA: Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses, Front Neuroendo-crinol 1996;17:1-50.
22. Gilkes AF, Ogden PH, Guild SB, Cramb G: Characterization of natriuretic peptide receptor subtypes in the AtT-20 pituitary tumour cell line, Biochcm J 1994:299(pt 2):481-487.
23. Hum PJ, Richards AM, Espiner EA, Nicholls MG, Yandle TG: Bioactivity and metabolism of C-type natriuretic peptide in normal man, J Clin Endocrinol Metab 1994;78:1428-1435.
24. Evans MJ, Mulligan RS, Livesey JH, Donald RA: The integrative control of adrenocortico-tropin secretion: A critical role for corticotropin-releasing hormone, J Endocrinol 1996:148: 475-483.
25. Livesey JH, Donald RA: Prevention of absorption losses during radioimmunoassay of polypeptide hormones: Effectiveness of albumins, gelatin, caseins, Tween 20 and plasma, Clin Chim Acta 1982;123:193-198.
26. Richter R, Schulz-Knappe P, Magert HJ, Mifune H, Schneidemann S, Forssmann WG: The equine endocrine heart: Morphology, biochemistry and molecular biology, Eur J Endocrinol 1994; 130(suppl 2):81.
27. Jennrich R, Sampson P, Franc J: P2V - analysis of variance and covariance including repeated measures; in Dixon WJ (ed): BMDP Statistical Software Manual, Los Angeles, University of California Press, 1985, pp 359-387.
28. Florkowski CM, Richards AM, Espiner EA, Yandle TG, Frampton C: Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men, Am J Physiol 1994;266:R1244-R1250.
29. Kokkonen U-M, Hackzell M, Rasancn LA: Plasma atrial natriuretic peptide in Stan-dardbred and Finnhorse trotters during and after exercise, Acta Physiol Scand 1995:154: 51-58.
30. McKeever KH, Hinchcliff KW, Schmall LM, Muir WW: Renal tubular function in horses during submaximal exercise, Am J Physiol 1991;261:R553-R560.
31. Irvine CHG, Alexander SL: A novel technique for measuring hypothalamic hormone secretion rates from collection of pituitary venous effluent in the normal horse, J Endocrinol 1987;1 13:183-192.
32. Tan TT, Yang Z, Huang W, Lim AT: ANF(I-28) is a potent suppressor of proopiomelanocortin (POMC) mRNA but a weak inhibitor of pEP-I.I release from AtT-20 cells, J Endocrinol 1994;143:R1-R4.